You have read all your free articles, to continue reading subscribe to read the rest of this content.
Via its subsidiary, Brighter Two AB, Brighter acquired Bestic, a Swedish robotics company that develops and sells products and assistive devices for the healthcare and nursing sector. In conjunction with the acquisition, Brighter Two, which develops and sells jDome BikeAround, is merged with BestAlready a subscriber Login You have read…
AstraZeneca and Merck & Co have announced that the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for Priority Review for the use of Lynparza (olaparib) tablets as a maintenance treatment in patients with newly-diagnosed, BRCA-mutated (BRCAm) advancAlready a subscriber Login You have read…
Denmark's Egalet has entered into a collaboration and license agreement with Shionogi. The collaboration and agreement regards the development and potential commercialization of multiple oral abuse-deterrent hydrocodone opioid product candidates using Egalet's proprietary technology. EgaletAlready a subscriber Login You have read all your free articles, to continue reading subscribe to read the rest of this content.…
The U.S. Food and Drug Administration (FDA) has given clearance to start the company's phase III clinical study CONCLUDE in the United States. The study will evaluate the efficacy and safety of the TLR9 agonist cobitolimod for the treatment of moderate to severe left-sided ulcerative colitis. Already a subscriber Login…
